Oxidant Stress and Thiol Redox State in Endothelial Cells

内皮细胞中的氧化应激和硫醇氧化还原态

基本信息

  • 批准号:
    7137155
  • 负责人:
  • 金额:
    $ 43.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-30 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

Normal oxidative metabolism leads to the generation of various redox forms of molecular oxygen, termed reactive oxygen species (ROS), that are generated over a range of concentrations within cells. Low levels of ROS production are important for normal signaling mechanisms, while higher levels of ROS production can lead to oxidant stress, a condition under which the flux of ROS exceeds antioxidant capacity. A key determinant of the response to oxidant stress is the cell's capacity to counter increased ROS generation by adaptively increasing the production of NADPH, the principal source of reducing equivalents for the reduction of oxidized glutathione. The primary cytosolic enzyme required for NADPH synthesis is glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme in the pentose phosphate pathway. We have previously demonstrated the importance of this enzyme in maintaining normal endothelial function, including nitric oxide (NO) bioactivity, in the face of oxidant stress. In this proposal, we hypothesize that G6PD and its enzymatic product NADPH are the key regulators of the thiol redox state of the endothelial cell, are essential for normal oxidant signaling and endothelial function, adaptively respond to increased ROS generation to maintain a state of compensated oxidant stress, and when oxidant stress exceeds this adaptive capacity are responsible for the conversion of compensated oxidant stress to uncompensated oxidant stress in the endothelial cell. To test this hypothesis, we will 1) assess the relationship between NADPH and the redox state of endothelial thiol pools and their enzymatic determinants; 2) evaluate the effect of NADPH on the synthesis, metabolism, and bioavailability of endothelial NO and its S-nitroso-derivatives; 3) determine the role of G6PD and NADPH in the adaptive response to oxidant stress in endothelial cells, including their role in supporting the state of compensated oxidant stress; and 4) evaluate the relationship between thiol redox state and endothelial NO bioactivity under conditions of normal oxidant signaling, compensated oxidant stress, and uncompensated oxidant stress in vivo. These studies should shed light on the critical role of G6PD and NADPH in regulating the thiol redox state of the endothelial cell and its ability to adapt to oxidant stress in an effort to maintain normal endothelial function.
正常的氧化代谢导致产生各种氧化还原形式的分子 氧,称为活性氧物质(ROS),在一定浓度范围内产生 在细胞内。低水平的ROS产生对于正常的信号传导机制是重要的,而 更高水平的ROS产生可导致氧化应激,在这种情况下, 超过了抗氧化能力。对氧化应激反应的一个关键决定因素是细胞的能力 为了通过适应性增加NADPH的产生来对抗增加的ROS产生, 用于还原氧化型谷胱甘肽的还原当量的来源。主要的胞浆酶 NADPH合成所需的是葡萄糖-6-磷酸脱氢酶(G6 PD), 磷酸戊糖途径中的酶。我们以前已经证明了这一点的重要性 酶在维持正常的内皮功能,包括一氧化氮(NO)的生物活性,在面对 氧化应激在这个提议中,我们假设G6 PD及其酶促产物NADPH是 内皮细胞巯基氧化还原状态的关键调节因子,对正常氧化信号传导至关重要 和内皮功能,适应性地响应增加的ROS产生,以维持一种状态, 当氧化应激超过这种适应能力时, 对于内皮细胞中代偿性氧化应激向非代偿性氧化应激的转化, cell.为了验证这一假设,我们将1)评估NADPH和氧化还原状态之间的关系, 内皮巯基池及其酶决定簇; 2)评估NADPH对内皮巯基池及其酶决定簇的影响。 内皮细胞NO及其S-亚硝基衍生物合成、代谢和生物利用度; 3)测定 G6 PD和NADPH在内皮细胞氧化应激适应性反应中的作用,包括 它们在支持补偿氧化应激状态中的作用;以及4)评估 巯基氧化还原状态和内皮NO生物活性之间的关系, 体内补偿氧化应激和未补偿氧化应激。这些研究应该 阐明G6 PD和NADPH在调节内皮细胞巯基氧化还原状态中的关键作用 及其适应氧化应激以维持正常内皮功能的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Loscalzo其他文献

Joseph Loscalzo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Loscalzo', 18)}}的其他基金

Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle Cells
血管平滑肌细胞中的支链酮酸和有氧糖酵解
  • 批准号:
    10731096
  • 财政年份:
    2023
  • 资助金额:
    $ 43.73万
  • 项目类别:
Center for Integrated Approached to Undiagnosed Diseases
未确诊疾病综合治疗中心
  • 批准号:
    10600194
  • 财政年份:
    2022
  • 资助金额:
    $ 43.73万
  • 项目类别:
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia
L-2-羟基戊二酸和缺氧中的代谢重塑
  • 批准号:
    10320786
  • 财政年份:
    2020
  • 资助金额:
    $ 43.73万
  • 项目类别:
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia
L-2-羟基戊二酸和缺氧中的代谢重塑
  • 批准号:
    10093718
  • 财政年份:
    2020
  • 资助金额:
    $ 43.73万
  • 项目类别:
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia
L-2-羟基戊二酸和缺氧中的代谢重塑
  • 批准号:
    10521282
  • 财政年份:
    2020
  • 资助金额:
    $ 43.73万
  • 项目类别:
Center for Integrated Approached to Undiagnosed Diseases
未确诊疾病综合治疗中心
  • 批准号:
    9788516
  • 财政年份:
    2014
  • 资助金额:
    $ 43.73万
  • 项目类别:
Center for Integrated Approached to Undiagnosed Diseases
未确诊疾病综合治疗中心
  • 批准号:
    10201702
  • 财政年份:
    2014
  • 资助金额:
    $ 43.73万
  • 项目类别:
Center for Integrated Approaches to Undiagnosed Diseases
未确诊疾病综合治疗中心
  • 批准号:
    8686403
  • 财政年份:
    2014
  • 资助金额:
    $ 43.73万
  • 项目类别:
Center for Integrated Approaches to Undiagnosed Diseases
未确诊疾病综合治疗中心
  • 批准号:
    9251865
  • 财政年份:
    2014
  • 资助金额:
    $ 43.73万
  • 项目类别:
Center for Integrated Approached to Undiagnosed Diseases
未确诊疾病综合治疗中心
  • 批准号:
    9593147
  • 财政年份:
    2014
  • 资助金额:
    $ 43.73万
  • 项目类别:

相似海外基金

Metabolomic Analysis of Redox control in Mycobacterium tuberculosis persisters
结核分枝杆菌持续存在氧化还原控制的代谢组学分析
  • 批准号:
    7980241
  • 财政年份:
    2010
  • 资助金额:
    $ 43.73万
  • 项目类别:
Metabolomic Analysis of Redox control in Mycobacterium tuberculosis persisters
结核分枝杆菌持续存在氧化还原控制的代谢组学分析
  • 批准号:
    8075073
  • 财政年份:
    2010
  • 资助金额:
    $ 43.73万
  • 项目类别:
Aging and Physical Functioning in HIV
艾滋病毒的衰老和身体机能
  • 批准号:
    7230643
  • 财政年份:
    2006
  • 资助金额:
    $ 43.73万
  • 项目类别:
Novel Catalases and their Products
新型过氧化氢酶及其产品
  • 批准号:
    7100044
  • 财政年份:
    2006
  • 资助金额:
    $ 43.73万
  • 项目类别:
Lycopene Chemoprevention of Lung Cancer in Ferret
番茄红素对雪貂肺癌的化学预防作用
  • 批准号:
    7036073
  • 财政年份:
    2006
  • 资助金额:
    $ 43.73万
  • 项目类别:
MRS Detects Metabolic Dysfunction after Brain Injury
MRS 检测脑损伤后代谢功能障碍
  • 批准号:
    7029334
  • 财政年份:
    2006
  • 资助金额:
    $ 43.73万
  • 项目类别:
Modes of Energy Production and clk-1 Life Extension
能量产生模式和 clk-1 寿命延长
  • 批准号:
    7040276
  • 财政年份:
    2006
  • 资助金额:
    $ 43.73万
  • 项目类别:
Metabolic Neuroprotection:Creatine Supplementation in Human Brain
代谢神经保护:人脑肌酸补充
  • 批准号:
    7226130
  • 财政年份:
    2005
  • 资助金额:
    $ 43.73万
  • 项目类别:
Novel methodology for studing oxidative metabolism
研究氧化代谢的新方法
  • 批准号:
    6851301
  • 财政年份:
    2005
  • 资助金额:
    $ 43.73万
  • 项目类别:
Novel methodology for studing oxidative metabolism
研究氧化代谢的新方法
  • 批准号:
    7014050
  • 财政年份:
    2005
  • 资助金额:
    $ 43.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了